艾可龙

中南大学湘雅药学院教授，药理系主任，临床药学研究与转化中心副主任，博士生导师，连续三年入选“全球顶尖前10万名科学家”榜单，全球前2%顶尖科学家榜单，湖南省杰出青年基金获得者，获吉林省自然科学一等奖2项，吉林省自然科学二等奖1项，华夏医学科技奖二等奖1项，中国科学院青年创新促进会会员、优秀会员，心血管研究湖南省重点实验室成员, 中国药理学会临床药学专业委员会常务委员。近年来在心血管修复等领域取得了多项创新成果，以一作或通讯作者身份发表包括在Adv. Mater.（IF=32.086，9篇）、iMETA(IF=33.2)、Molecular Cancer (IF=33.9，2篇)、Bioactive Materials（IF=20.3,9篇）、Nat. Commun.(IF=16.6，3篇)、J. Am. Chem. Soc.（IF=16.383，3篇）、Angew. Chem. Int. Ed（IF=16.823，3篇）、Exploration (IF=22.5) 、Adv. Funct. Mater.（IF=19.924, 2篇）、Adv. Sci.（IF=17.521，7篇）、ACS Nano (IF=15.8，2篇) 等国际权威学术期刊上80篇，他引>2万次，H-因子为55。相关研究成果多次被 Nature Nanotechnology、Nature Chemistry等作为研究亮点报道。担任20余个国际主要学术期刊审稿人，4个SCI期刊的编委或青年编委成员。申请发明专利20余项，其中12项已获授权。

邮箱：aikelong@csu.edu.cn，欢迎本科生、硕士生、博士生与博士后加入研究团队，要求：做事认真，善于沟通，敢想敢干，执行力强。

研究领域： 1.  氧化应激在心脑血管损伤的机制研究；

2.   纳米药物在心脑血管修复的研究。

教育经历：

1.  武汉大学  本科

2.   国科大   硕士

3.   吉林大学  博士

工作经历：

1.  2002.07-2019年10月 中国科学院长春应用化学研究所，历任研究实习员，助理研究员，副研究员

2.  2019.11至今 中南大学湘雅药学院，教授

科研项目：

1. 主持国家自然科学基金面上项目（3项）、青年项目、湖南省重点研发、湖南省杰青、中科院青促会优秀会员等15项研究课题；

2.  作为核心骨干成员参与科技部国家重点研发计划2项、国家自然科学基金重点项目1项等多个科研课题研究。

奖励和荣誉：

1.  吉林省自然科学一等奖(2018,排名第3）；

2.  吉林省自然科学二等奖(2020,排名第3）；

3.  吉林省自然科学一等奖(2012,排名第8）；

4.  华夏医学科技奖二等奖(2025,排名第2）。

学术兼职

1.  《中南大学学报（医学版）》编委；

2.    中国药理学会临床药学专业委员会常委委员；

团队成员成果（新课题组，硕士从2020年招生、博士从2021年开始招生）

1. 王淑雅，2022级博士，湖南省研究生医学创新大赛三等奖，获威尔曼奖学金，已在课题组发表SCI论文11篇（IF为32.08, 32.08, 22.5，20.3，17.521，16, 16.6, 16.6, 15.8, 13.2, 10.269） 

2.陈俏慧，2023级博士，湖南省研究生医学创新大赛三等奖，获威尔曼奖学金，已在课题组发表11篇SCI论文（IF为 32.08, 33.9, 20.3，20.3, 19, 17.521, 16.744，9.7，6.064，5.988, 5.988） 

3. 王珏，2024级博士，已在课题组发表SCI论文1篇（IF为20.2）

4.张蕴韬，2024级本-博，已在课题组发表SCI论文1篇（IF为33.2）

4.时肖静，2025级博士，已在课题组发表1篇SCI论文（IF为 22.5）

5.林玉婷，2025级博士，已在课题组发表1篇SCI论文（IF为13.2）

7.应晓红，2023级硕士，已在课题组发表SCI论文1篇（IF为33.9）

8. 熊廷黎，2023级硕士，已在课题组发表SCI论文1篇（IF为20.3）

9. 黄运莹，2023级硕士

10.郑文煊，2024级硕士

11.吴紫宇，2024级硕士

12.夏颖慈，2024级硕士

13.李睿诗，2024级硕士，已在课题组发表1篇SCI论文（IF为13.2）

14.曾宛，2024级硕士

15.苗晨曦，2025级本-博

16.袁文钦，2025级硕士

17.李飞，2025级硕士

18.位佳文，2025级硕士

19.蔡依凯，2025级硕士

已毕业学生

2023年毕业

1.  陈俏慧，2020级硕士，湖南省研究生医学创新大赛三等奖，获威尔曼奖学金，已在课题组发表3篇SCI论文（IF分别为16.874, 16.744，5.988）， 中南大学本课题攻读博士 

2.  黄佳，2020级硕士，湖南省自然科学一等优秀学术论文,  获威尔曼奖学金，已在课题组发表4篇SCI论文（IF分别为17.521，17.521，8.301，5.988），南方科技大学攻读博士 

3.  陈立，2020级硕士，获威尔曼奖学金，已在课题组发表SCI论文2篇 （IF分别为11.799，6.025 ） ，澳门大学攻读博士 

2024年毕业

4.  肖祚庥，2021级硕士，获威尔曼奖学金，中南大学优秀学生, 湖南省研究生医学创新大赛三等奖，已在课题组发表2篇（IF分别为16.744，11.6），澳门大学攻读博士  

5.  杨禹琪，2021级硕士，获国家奖学金2次，已在课题组发表SCI论文5篇（IF分别为17.521，16.874，10.761，15.153, 7） ，香港理工大学攻读博士

6.  向羽婷，2021级硕士，获威尔曼奖学金, 中南大学优秀学生，中南大学优秀毕业生，已在课题组发表SCI论文3篇（IF分别为19，5.988，5.988）， 入职武汉大学口腔医院

7.  龙星余，2021级硕士，获威尔曼奖学金, 中南大学优秀学生，中南大学优秀毕业生，已在课题组发表SCI论文2篇（IF分别为32.086，5.988），入职华中科技大学同济医学院附属协和医院

2025年毕业

5.杨咏琪，2022级硕士，获国家奖学金, 威尔曼奖学金，已在课题组发表SCI论文2篇（IF为32.08, 5.988, 9.7）  南方科技大学攻读博士

6.齐维敏，2022级硕士,已在课题组发表SCI论文2篇（IF为9.7， 20.2） 参加工作

7. 时肖静，2022级硕士，已在课题组发表SCI论文1篇（IF为22.5）中南大学本课题攻读博士

8.  赵天娇，2021级博士，获周宏灏药学优秀学生奖，已在课题组发表6篇SCI论文（IF为20.3，20.722，20.3，17.521，9.7，4.8），合肥师范学院工作

2026年度

80. Wensheng Chen†, Yuntao Zhang†, Jue Wang, Yiming Li, Hao Wu, Qiong Huang*, Wei Wu*, Kelong Ai*, Oral proton-reprogrammed nanomedicine to break the inflammatory bowel disease-Clostridium difficile infection vicious cycle, iMETA, 2026; Just Accept,  IF=33.2

79. Weimin Qi†,Jue Wang†, Shuya Wang, Xiaojing Shi, Tingli Xiong, Ruishi Li, Wenxuan Zheng, Min Liu, Shusheng Deng, Qiong Huang*, Jianhua Liu*,  Kelong Ai*. Heart-homed Fast Acting Mitochondrial-function Enhancer Nanomedicine for Cardiac Function Recovery of Post-Myocardial Infarction via Mitochondrial Function Restoration, Bioactive Materials, 2026; Just Accept,  IF=20.3

78. Shuya Wang†, Yuting Lin†, Tianjiao Zhao, Xiaojing Shi, Tingli Xiong, Ruishi Li, Wenxuan Zheng, Min Liu, Fei Li, Jiawen Wei, Qian Lin, Qiong Huang*, Yayun Nan*,  Kelong Ai*,  Dual Fe²⁺-clean (DFC) nanotherapeutic system: A precise and synergistic therapy for myocardial ischemia-reperfusion injury via source blockade of mitoNEET, Chemical. Engineering Journal,2026; Just Accepted,  IF=13.2

77. Jinjin Liu†, Dan Wang†, Shuya Wang†, Xiaojing Shi, Tingli Xiong, Yebin Lu, Jianbo Yang, Wei Wei, Xuejun Gong, Qiong Huang*, Liandong Ji*, Kelong Ai*,  Dual-targeted molybdenum nanomedicine treats acute pancreatitis by blocking mitochondrial DNA-triggered cGAS-STING signaling via ROS modulation, Journal of Controlled Release,2026; Just Accepted,  IF=11.5

2025年度

76. Xiaohui Gong†, Shuya Wang†, Jiaxiong Zhang, Hongqin Ma, Quan Sun, Meilian Yao, Jing Chen, Jian Zhang, Qun Huang, Xiaojing Shi, Weimin Qi, Yuting Lin, Baiyang You, Yongping Bai*, Guogang Zhang*, Kelong Ai*,  Tannin-Mediated Ischemia-Homing-Angiogenesis Nanodots (IHAND) for Synergistic Angiogenesis and Heart Failure Prevention Post-Myocardial Infarction, Adv. Mater.,2025; Just Accepted,  IF=32.086

75. Shuya Wang†, Ruishi Li†, Xiaojing Shi, Tingli Xiong, Wenxuan Zheng, Weimin Qi, Min Liu, Lin Dai, Qian Lin, Rui Huang, Wei Dai, Min Zhou, Qiong Huang* Junlin Jiang*, Xiaoying Wang*, Kelong Ai*,  Sequential Targeted Nanomedicine MPC Treats Cerebral Ischemia-Reperfusion Injury via Neuronal Microenvironment Reprogramming, Chemical. Engineering Journal, Just Accepted,  IF=13.2

74.Yongqi Yang#, Qiaohui Chen#, Xiaohong Ying, Ziyu Wu, Wan Zeng, Chenxi Miao, Yayun Nan, Qiong Huang*,  Kelong Ai*,  Fully Biocompatible Tantalum-Based Antioxidant Nanoshields for Proximal Tubule Epithelial Cells-Targeted Mitochondrial Holistic Protection in Acute Kidney Injury Adv. Mater.,2025; Just Accepted,  IF=32.086

73. Shuya Wang, Xiaojing Shi, Tingli Xiong, Wenxuan Zheng, Ruishi Li, Weimin Qi, Min Liu, Lin Dai, Min Zhou, Wei Dai, Qiong Huang*, Xiaoying Wang*, Kelong Ai*, Unlocking Neuroprotection: Simultaneous Suppression of Mitochondrial Energetic Collapse and Oxidative-Inflammatory Vortex for ischemia-reperfusion Brain Injury, ACS NANO, 2025; Just Accepted,  IF=16

72. Shuya Wang, Yuting Xiang, Xiaojing Shi, Tingli Xiong, Ruishi Li, Wenxuan Zheng, Wensheng Chen, Qiaohui Chen, Yongqi Yang, Jue Wang, Qiong Huang*, Kelong Ai*, An eNOS-like nanomaterial for specific reversal of cerebral ischemia-reperfusion injury. Nature Communications, 2025; Just Accepted, IF=16.6

71. Zerun Liu#, Wensheng Chen#, Jinping Zhang, Ting Huang, Ying Hong, Tianjiao Zhao, Min Liu, Qiaohui Chen, Yongqi Yang, Shuya Wang, Jue Wang, Xiaohong Ying, Yiming Li, Qiong Huang*, Kelong Ai*, UCP2 inhibition eliminates pancreatic β cell autoinflammation in type 2 diabetes mellitus with Islet-mitochondrial sequential targeting nanomeidicnes, Nature Communications, 2025; , 2025; 16 (1), 6840.  IF=16.6

70. Qiaohui Chen, Zuoxiu Xiao, Xiaohong Ying, Yongqi Yang, Jianlin Chen, Ziyu Wu, Wan Zeng, Chenxi Miao, Yayun Nan, Qiong Huang*, Kelong Ai*, Molybdenum-bridged endo-exogenous antioxidant synergy reverses acute kidney injury via mitochondrial homeostasis reconstruction. Bioactive Materials, 2025; 54, 777-796. IF=20.3

69. Tingli Xiong†, Shuya Wang†, Xiaojing Shi, Ruishi Li, Wenxuan Zheng, Weimin Qi, Min Liu, Lin Dai, Qiong Huang*, Kelong Ai*, Biomimetic dynamic nanomedicine SrHCF: Lattice self-reconstruction based on Fe²⁺ response to achieve synergistic “ferrous chelation-antioxidation-calcium antagonism-inflammation inhibition” quadruple treatment of CIRI.,  Bioactive Materials,2025; Just Accept,  IF=20.3

68. Tianjiao Zhao, Yunying Huang, Wensheng Chen, Weimin Qi, Jue Wang, Yingci Xia, Jia Zhou, Xingyu Long, Yayun Nan, Qiong Huang*, Kelong Ai*, Polydopamine as a Biocompatible and Precise Mitochondrial Targeted Therapeutic Platform for Reversing Myocardial Ischemia-Reperfusion Injury,  Bioactive Materials, 2025; Just Accept,  IF=20.3

67. Fang Zhao, Zeyu Hu, Gejing Li, Min Liu, Qiong Huang*, Kelong Ai*, Xiong Cai*,Polydopamine as a Biocompatible and Precise Mitochondrial Targeted Therapeutic Platform for Reversing Myocardial Ischemia-Reperfusion Injury,  Bioactive Materials, 2025; Just Accept,  IF=20.3

66. Qian Zeng, Min Liu, Ziqi Wang, Rongrong Zhou*, Kelong Ai*, Enhancing Radiotherapy-induced Anti-tumor Immunity via Nanoparticle-mediated STING Agonist Synergy, Molecular Cancer, 2025; 1-43,  IF=33.9

65. Xiaojing Shi#, Shuya Wang#, Tingli Xiong, Ruishi Li, Wenxuan Zheng, Wensheng Chen, Tianjiao Zhao, Yongqi Yang, Xiaohong Ying, Weimin Qi, Yingci Xia, Jue Wang, Qiong Huang*, Kelong Ai*, Specifically breaking through the injured blood-brain barrier with tannic acid-based nanomedicine for ischemic stroke ischemia reperfusion treatment, Exploration, 2025;0:20240388,  IF=22.5

64. Zerun Liu#, Ting Huang#, Ying Hong#, Yuqi Yang, Wensheng Chen, Qingtao Zeng, Qiaohui Chen, Yongqi Yang, Xiaohong Ying, Wan Zeng, Ziyu Wu, Tianjiao Zhao, Xuesi Wan, Jianlin Chen, Kelong Ai*, Qiong Huang*,  Adaptive Antioxidant Nanomedicines Inhibit Ferroptosis in Renal Tubular Epithelial Cells to Alleviate Diabetic Kidney Disease, Adv. Sci., 2025; e05168,  IF=17.521

63. Dan Wang#, Shuya Wang#, Jinjin Liu, Xiaojing Shi, Tingli Xiong, Ruishi Li, Wei Wei, Liandong Ji, Qiong Huang*, Xuejun Gong*, Kelong Ai*, Nanomedicine Penetrating Blood-Pancreas Barrier for Effective Treatment of Acute Pancreatitis, Adv. Sci., 2025;  https://doi.org/10.1002/advs.202413925,  IF=17.521

2024年度

62. Shuya Wang, Xiaojing Shi, Tingli Xiong, Qiaohui Chen, Yongqi Yang, Wensheng Chen, Kexin Zhang, Yayun Nan, Qiong Huang*, Kelong Ai*, Inhibiting Mitochondrial Damage for Efficient Treatment of Cerebral Ischemia-Reperfusion Injury through Sequential Targeting Nanomedicine of Neuronal Mitochondria in Affected Brain Tissue, Adv. Mater., 2024;  2409529,  IF=32.086

61. Xingyu Long#, Min Liu#, Yayun Nan#, Qiaohui Chen, Zuoxiu Xiao, Yuting Xiang, Xiaohong Ying, Jian Sun, Qiong Huang*, Kelong Ai*, Revitalizing Ancient Mitochondria with Nano-strategies: Mitochondria-remedying Nanodrugs Concentrate on Disease Control, Adv. Mater., 2024;  2308239, IF=32.086，高被引

60. Xiaohong Ying#, Qiaohui Chen#, Yongqi Yang, Ziyu Wu, Wan Zeng, Chenxi Miao, Qiong Huang*, Kelong Ai*, Nanomedicines Harnessing cGAS-STING Pathway: Sparking Immune Revitalization to Transform 'Cold' Tumors into 'Hot' Tumors, Molecular Cancer, 2024; 23, 277.  IF=33.9

59. Chuang Yuan#, Qicai Xiao#, Qiaohui Chen, Qiong Huang, Kelong Ai*, Xinyu Yang*, Anticoagulant Therapy without Bleeding: A Novel Molybdenum-based Nanodots Alleviate Lethal Coagulation in Bacterial Sepsis by Inhibiting ROS-facilitated Caspase-11 Activation, SmartMat, 2024; e1264,  IF=20.4

58. Yuting Xiang^#, Qiaohui Chen^#, Yayun Nan^#, Min Liu, Zuoxiu Xiao, Yuqi Yang, Jinping Zhang, Xiaohong Ying, Xingyu Long, Shuya Wang, Jian Sun, Qiong Huang^*, Kelong Ai^*, Nitric Oxide-Based Nanomedicines for Conquering TME Fortress: Say “NO” to Insufficient Tumor Treatment, Adv. Functional Mater., 2024; 2312092,  IF=19.924

57. Yamei Liu^#, Shuya Wang^#, Jiaxiong Zhang, Quan Sun , Yi Xiao , Jing Chen , Meilian Yao, Guogang Zhang, Qun Huang, Tianjiao Zhao, Qiong Huang, Xiaojing Shi , Can Feng, Jian Sun, Kelong Ai*, Yongping Bai^*, Reprogramming the Myocardial Infarction Microenvironment with Melanin Composite Nanomedicine,  Nat. Commun., 2024;  15, 6651.  IF=16.6

56. Jiaxiong Zhang#, Shuya Wang#, Quan Sun, Jian Zhang, Xiaojing Shi, Meilian Yao, Jing Chen, Qiong Huang, Guogang Zhang, Qun Huang, Kelong Ai*, Yongping Bai*, ONOO^- free NO-embedded Nanoparticle (OFEN) Maintains NO Homeostasis for Effective Revascularization of Myocardial Infarcts, ACS Nano,  2024; 18, 32650,  IF=16

55. Qiaohui Chen, Yongqi Yang, Xiaohong Ying, Changkun Huang, Jianlin Chen, Jue Wang, Ziyu Wu, Wan Zeng, Chenxi Miao, Xiaojing Shi, Qiong Huang*, Kelong Ai*, Hierarchical Targeting Nanodrug with Holistic DNA Protection for Effective Treatment of Acute Kidney Injury, Adv. Sci., 2024;  2411254, IF=17.521

2023年度

54. Mingyuan Wang#, Qiong Huang#, Min Liu, Tianjiao Zhao, Xiangping Song, Qiaohui Chen, Yongqi Yang, Yayun Nan, Zerun Liu, Yuntao Zhang, Wei Wu*, Kelong Ai*, Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin-α Embedded Nanomedicine (OPEN), Adv. Mater., 2023; 35(49),  2309370, IF=32.086

53. Xiangping Song#, Qiong Huang#, Yuqi Yang, Liang Ma, Wenguang Liu, Chunlin Ou, Qiaohui Chen, Tianjiao Zhao, Zuoxiu Xiao, Mingyuan Wang, Yitian Jiang, Yunrong Yang, Jinping Zhang, Yayun Nan, Wei Wu*, Kelong Ai*, Efficient Therapy of Inflammatory Bowel Disease (IBD) with Highly Specific and Durable Targeted Ta₂C Modified with Chondroitin Sulfate (TACS), Adv. Mater., 2023; 35(36), 2301585,  IF=32.086

52. Qiong Huang, Yuqi Yang, Tianjiao Zhao, Qiaohui Chen, Min Liu, Shuting Ji, Yan Zhu, Yunrong Yang, Jinping Zhang, Haixin Zhao, Yayun Nan, Kelong Ai*, Passively-targeted Mitochondrial Tungsten-based Nanodots for Efficient Acute Kidney Injury Treatment. Bioactive Materials. 2023,21,381-393. IF=20.3，高被引

51. Qiaohui Chen#, Yayun Nan#, Yuqi Yang, Zuoxiu Xiao, Min Liu, Jia Huang, Yuting Xiang, Xingyu Long, Tianjiao Zhao, Xiaoyuan Wang, Qiong Huang*, Kelong Ai*. Nanodrugs Alleviate Acute Kidney Injury: Manipulate RONS at Kidney. Bioactive Materials. 2023, 22, 141-167.   IF=20.3，高被引，热点论文

50. Jia Huang#, Guiming Deng#, Shuya Wang, Tianjiao Zhao, Qiaohui Chen, Yuqi Yang, Yongqi Yang, Jinping Zhang, Yayun, Nan, Zhaoqian Liu, Ke Cao, Qiong Huang*, Kelong Ai*, A NIR-II Photoactivatable “ROS Bomb” with High-density Cu₂O-supported MoS₂ Nanoflowers for Anticancer Therapy, Adv. Sci., 2023, 10(24), 2302208. IF=17.521

49. Qiong Huang, Zerun Liu, Yunrong Yang, Yuqi Yang, Ting Huang, Ying Hong, Jinping Zhang, Qiaohui Chen, Tianjiao Zhao, Zuoxiu Xiao, Xuejun Gong, Yitian Jiang, Jiang Peng, Yayun Nan, Kelong Ai*, Selenium nanodots (SENDs) as antioxidants and antioxidant-prodrugs to rescue islet β cells in type 2 diabetes mellitus by restoring mitophagy and alleviating endoplasmic reticulum stress, Adv. Sci., 2023, 10(19), 2300880. IF=17.521

48. Quan Sun, Hongqin Ma, Jiaxiong Zhang, Baiyang You, Xiaohui Gong, Xiaolin Zhou, Jin Chen, Guogang Zhang, Jia Huang, Qiong Huang, Yurong Yang, Kelong Ai*, Yongping Bai*, A Self-Sustaining Antioxidant Strategy for Effective Treatment of Myocardial Infarction. Adv. Sci., 2023, 10(5), 2204999. IF=17.521

47. Yunrong Yang#, Jia Huang#, Min Liu, Qiaohui Chen, Tianjiao Zhao, Zuoxiu Xiao, Yuqi Yang, Qiong Huang*, Kelong Ai*, Emerging Sonodynamic Therapy-based Nanomedicines for Cancer Immunotherapy, Adv. Sci., 2023, 10(2), 2204365, IF=17.521

46. Qiong Huang, Yuqi Yang, Yan Zhu, Qiaohui Chen, Tianjiao Zhao, Zuoxiu Xiao, Mingyuan Wang, Xiangping Song, Yitian Jiang, Yunrong Yang, Jinping Zhang, Yang Xiao, Yayun Nan, Wei Wu*, Kelong Ai*, Oral Metal-free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD), Small, 2023, 19(19), 2207350, IF=15.153

45. Hong Liu, Shuya Wang, Qiaohui Chen, Xiaoyue Ge, Huang Ning, Yanzi Guo, Di Wang, Kelong Ai*, Changping Hu*, Natural Targeting Potent ROS-eliminating Tungsten-based Polyoxometalate Nanodots for Efficient Treatment of Pulmonary Hypertension, Adv. Healthcare Mater., 2023, 12(22),  202300252, IF=11.092

44.  Shuya Wang, Qiaohui Chen. Tianjiao Zhao, Kelong Ai*, Changping Hu*, Nanomedicine-based treatment: an emerging therapeutical strategy for pulmonary hypertension, Nano Research, 2023, 16(5), 4007-7029, IF=10.269

43. Haixin Zhao, Jia Huang, Lulu Huang, Yuqi Yang, Zuoxiu Xiao, Qiaohui Chen, Qiong Huang*, Kelong Ai*. Surface control approach for growth of cerium oxide on flower-like molybdenum disulfide nanosheets enables superior removal of uremic toxins. Journal of Colloid and Interface Science, 2023, 630, 855-865. IF=9.965 

42.Yuqi Yang#, Yayun Nan#, Zuoxiu Xiao, Yuntao Zhang, Huanan Zhang,  Qiong Huang*, Kelong Ai*, Antioxidative 0-dimensional Nanodrugs Overcomes Obstacles in AKI Antioxidant Therapy, Journal of Materials Chemistry B, 2023, 11(34), 8081-8095. IF=7

41. Qiaohui Chen#, Xiaoyuan Wang#, Chao Yuan#, Yayun Nan*, Qiong Huang*, Kelong Ai*. 2D-nanomaterials for AKI treatment, Frontiers in Bioengineering and Biotechnology, 2023, 11, 1159989. IF=6.064

2022年度

40. Yan Zhu#, Tianjiao Zhao#, Min Liu, Shuya Wang, Saili Liu, Yunrong Yang, Yuqi Yang, Yayun Nan, Qiong Huang*, Kelong Ai*.  Rheumatoid Arthritis Microenvironment Insights into Treatment Effect of Nanomaterials. Nano Today. 2022; 42, 101358. IF=20.722  高被引

39. Zhao Tianjiao#, Wu Wei#, Sui Lihua, Huang Qiong*, Nan Yayun, Liu Jianhua, Ai Kelong*. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioactive Materials. 2022; 7, 47-72. IF=20.3 高被引，热点论文

38. Yuqi Yang^#, Tianjiao Zhao^#, Qiaohui Chen, Yumei Li, Zuoxiu Xiao, Yuting Xiang, Boyu Wang, Yige Qiu, Shiqi Tu, Yitian Jiang, Yayun Nan, Qiong Huang*, Kelong Ai*, Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC, Adv. Sci., 2022;  2202797, IF=17.521

37. Haixin Zhao, Jia Huang, Lu Miao, Yuqi Yang, Zuoxiu Xiao, Qiaohui Chen, Qiong Huang*, Kelong Ai*, Toward Urease-Free Wearable Artificial Kidney: Widened Interlayer Spacing MoS₂ Nanosheets with Highly Effective Adsorption for Uremic Toxins.  Chemical. Engineering Journal, 2022, 438, 135583. IF=16.744

36. Zuoxiu Xiao#, Qiaohui Chen#, Yuqi Yang, Shiqi Tu, Boyu Wang, Yige Qiu, Yitian Jiang, Qiong Huang*, Kelong Ai*,  Chemical. Engineering Journal, 2022; 137889, IF=16.744

35. Min Liu, Yuting Xiang, Yuqi Yang, Xingyu Long, Zuoxiu Xiao, Yayun Nan,Yige Qiu, Yitian Jiang, Qiong Huang*, Kelong Ai*,  Biosensors and Bioelectronics, 2022;114758, IF=12.6

34. Zuoxiu Xiao, Qiong Huang, Yuqi Yang, Min Liu, Qiaohui Chen, Jia Huang, Yuting Xiang, Xingyu Long, Tianjiao Zhao, Xiaoyuan Wang, Xiaoyu Zhu, Shiqi Tu, Yayun Nan, Kelong Ai*, Emerging early diagnostic methods for acute kidney injury. Theranostics, 2022, 12(6): 2963-2986.  IF=12.4

33. Min Liu, Qiong Huang, Yan Zhu, Li Chen, Yumei Li, Zhicheng Gong*, Kelong Ai*, Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury. Materials Today Bio. 2022, 13, 100218. IF=10.761 高被引

32. Yuqi Yang, Qiong Huang, Zuoxiu Xiao, Min Liu, Yan Zhu, Qiaohui Chen, Yumei Li, Kelong Ai*, Nanomaterial-based biosensor developing as a route toward in vitro diagnosis of early ovarian cancer. Materials Today Bio. 2022, 13, 100218. IF=10.761

31. Yuan, Chuang#; Ai, Kelong#; Xiang, Menghua; Xie, Chengliang; Zhao, Mingyi; Wu, Ming; Li, Hongli; Wu, Yueren; Cao, Yueqing; Li, Can; Zhong, Yanjun; Pei, Xiaomeng; Law, Helen Ka Wai; Gao, Liqian; Xiao, Qicai*; Yang, Xinyu*, Novel 1-hydroxy phenothiazinium-based derivative protects against bacterial sepsis by inhibiting AAK1-mediated LPS internalization and caspase-11 signaling. Cell Death & Disease, 2022, 13(8), 722. IF=9.685

30. Jia Huang, Qiong Huang, Min Liu, Qiaohui Chen, Kelong Ai*, Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy. Frontiers in Pharmacology, 2022, 13, 844037. IF=5.81 高被引

2021年度

29. Wang Jianling#, Sui Lihua#, Huang Jia, Miao Lu, Nie Yubing, Wang Kuansong, Yang Zhichun*, Huang Qiong, Gong Xue, Nan Yayun, Ai Kelong*. MoS₂-based nanocomposites for cancer diagnosis and therapy. Bioactive Materials. 2021; 6(11): 4209-4242. IF=20.3 高被引，热点论文，Bioactive Materials-Best Paper Award 2021

28. Chen Li#, Huang Qiong#, Zhao Tianjiao, Sui Lihua, Wang Shuya, Xiao Zuoxiu, Nan Yayun, Ai Kelong*. Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19. Redox Biology. 2021; 45: 102046-102046. IF=11.799

27. Li Zelun#, Wang Juan#, Chen Qian, Ai Kelong*, Lu Lehui*. Hierarchically porous polymer with ultra-high affinity for bisphenol A enables high efficient water purification. Science China Chemistry. 2021. IF=10.138

26. Kelong Ai, Jia Huang, Zuoxiu Xiao, Yuqi Yang, Yuwang Bai, Jun Peng*. Localized surface plasmon resonance properties and biomedical applications of copper selenide nanomaterials. Materials Today Chemistry. 2021; 8:100402. IF=8.301

2020年度

25. Yu Bin, Ai Kelong*, Lu Lehui*. Dual-protective nano-sunscreen enables high-efficient elimination of the self-derived hazards. Applied Materials Today. 2020; 18. IF=10.041

24. Sui Lihua#, Wang Jianling#, Xiao Zuoxiu, Yang Yuqi, Yang Zhichun*, Ai Kelong*. ROS-Scavenging Nanomaterials to Treat Periodontitis. Frontiers in Chemistry. 2020; 8. IF=5.221

23. Li Niansheng, Chen Li, Xiao Zuoxiu, Yang Yuqi, Ai Kelong*. Progress in Detection of Biomarker of Ovarian Cancer: Lysophosphatidic Acid. Chinese Journal of Analytical Chemistry. 2020; 48(12): 1597-1606. IF=1.134

22. Huang Qiong, Wu Wei*, Ai Kelong*, Liu Jianhua. Highly Sensitive Polydiacetylene Ensembles for Biosensing and Bioimaging. Frontiers in Chemistry. 2020; 8. IF=5.221

2019年以前

21. Wang Juan, Li Zelun, Wang Ying, Wei Changting, Ai Kelong*, Lu Lehui*. Hydrogen bond-mediated strong adsorbent-I₃^- interactions enable high-efficiency radioiodine capture. Materials Horizons. 2019; 6(7): 1517-1525. IF=15.717

20. Wang Juan, Ai Kelong*, Lu Lehui*. Flame-retardant porous hexagonal boron nitride for safe and effective radioactive iodine capture. Journal of Materials Chemistry A. 2019; 7(28): 16850-16858. IF=14.511

19. Li Zelun, Chang Xuling, Wang Ying, Wei Changting, Wang Juan, Ai Kelong*, Zhang Ye*, Lu Lehui*. Point-and-Shoot Strategy for Identification of Alcoholic Beverages. Analytical Chemistry. 2018; 90(16): 9838-9844. IF=8.008

18. Ai Kelong, Li Zelun, Li Weiwei, Fan Jinchang, Cui Xiaoqiang*, Zheng Weitao. Robust Synthesis of High-Performance N-Graphite Hollow Nanocatalysts Based on the Ostwald Ripening Mechanism for Oxygen Reduction Reaction Electrocatalysis. Particle & Particle Systems Characterization. 2018; 35(10). IF=3.310

17. Wang Ying, Pei Hanwen, Jia Yan, Liu Jianhua, Li Zelun, Ai Kelong*, Lu Zhongyuan, Lu Lehui*. Synergistic Tailoring of Electrostatic and Hydrophobic Interactions for Rapid and Specific Recognition of Lysophosphatidic Acid, an Early-Stage Ovarian Cancer Biomarker. Journal of the American Chemical Society. 2017; 139(33): 11616-11621. IF=16.383

16. Liu Yanlan#, Ai Kelong#, Ji Xiaoyuan, Askhatova Diana, Du Rose, Lu Lehui*, Shi Jinjun*. Comprehensive Insights into the Multi-Antioxidative Mechanisms of Melanin Nanoparticles and Their Application To Protect Brain from Injury in Ischemic Stroke. Journal of the American Chemical Society. 2017; 139(2): 856-862. IF=16.383

15. Li Zelun#, Ai Kelong#, Yang Zhe, Zhang Tianqi, Liu Jianhua, Cui Xiaoqiang*. Untrasmall Bi₂S₃ nanodots for in vivo X-ray CT imaging-guided photothermal therapy of cancer. RSC Advances. 2017; 7(47): 29672-29678. IF=4.036

14. Ai Kelong, Li Zelun, Cui Xiaoqiang*. Scalable preparation of sized-controlled Co-N-C electrocatalyst for efficient oxygen reduction reaction. Journal of Power Sources. 2017; 368: 46-56. IF=9.794

13. Ruan Changping, Shen Mengxia, Ren Xiaoyan, Ai Kelong*, Lu Lehui*. A Versatile and Scalable Approach toward Robust Superhydrophobic Porous Materials with Excellent Absorbency and Flame Retardancy. Scientific Reports. 2016; 6. IF=4.379

12. Ai Kelong, Ruan Changping, Shen Mengxia, Lu Lehui*. MoS₂ Nanosheets with Widened Interlayer Spacing for High-Efficiency Removal of Mercury in Aquatic Systems. Advanced Functional Materials. 2016; 26(30): 5542-5549. IF=19.924

11. Shen Mengxia, Zheng Li-Rong, He Wenhui, Ruan Changping, Jiang Chunhuan, Ai Kelong*, Lu Lehui*. High-performance oxygen reduction electrocatalysts derived from uniform cobalt-adenine assemblies. Nano Energy. 2015; 17: 120-130. IF=19.096

10. Shen Mengxia, Ruan Changping, Chen Yan, Jiang Chunhuan, Ai Kelong*, Lu Lehui*. Covalent Entrapment of Cobalt-Iron Sulfides in N-Doped Mesoporous Carbon: Extraordinary Bifunctional Electrocatalysts for Oxygen Reduction and Evolution Reactions. ACS Applied Materials & Interfaces. 2015; 7(2): 1207-1218. IF=10.383

9. He Wenya, Ai Kelong*, Lu Lehui. Nanoparticulate X-ray CT contrast agents. Science China-Chemistry. 2015; 58(5): 753-760. IF=10.138

8. Ruan Changping#, Ai Kelong#, Li Xingbo, Lu Lehui*. A Superhydrophobic Sponge with Excellent Absorbency and Flame Retardancy. Angewandte Chemie-International Edition. 2014; 53(22): 5556-5560. IF=16.823

7. Liu Yanlan#, Ai Kelong#, Liu Jianhua, Deng Mo, He Yangyang, Lu Lehui*. Dopamine-Melanin Colloidal Nanospheres: An Efficient Near-Infrared Photothermal Therapeutic Agent for In Vivo Cancer Therapy. Advanced Materials. 2013; 25(9): 1353-1359. IF=32.086

6. Li Meili, Sun Guoying*, Yin Pingping, Ruan Changping, Ai Kelong*. Controlling the Formation of Rodlike V₂O₅ Nanocrystals on Reduced Graphene Oxide for High-Performance Supercapacitors. ACS Applied Materials & Interfaces. 2013; 5(21): 11462-11470. IF=10.383

5. Ai Kelong#, Liu Yanlan#, Ruan Changping, Lu Lehui*, Lu Gaoqing*. Sp² C-Dominant N-Doped Carbon Sub-micrometer Spheres with a Tunable Size: A Versatile Platform for Highly Efficient Oxygen-Reduction Catalysts. Advanced Materials. 2013; 25(7): 998-1003. IF=32.086

4. Ai Kelong, Liu Yanlan, Lu Lehui*, Cheng Xiaoli, Huo Lihua. A novel strategy for making soluble reduced graphene oxide sheets cheaply by adopting an endogenous reducing agent. Journal of Materials Chemistry. 2011; 21(10): 3365-3370. IF=12.732

3. Ai Kelong, Liu Yanlan, Liu Jianhua, Yuan Qinghai, He Yangyang, Lu Lehui*. Large-Scale Synthesis of Bi₂S₃ Nanodots as a Contrast Agent for In Vivo X-ray Computed Tomography Imaging. Advanced Materials. 2011; 23(42): 4886-4891. IF=32.086

2. Ai Kelong, Zhang Baohua, Lu Lehui*. Europium-Based Fluorescence Nanoparticle Sensor for Rapid and Ultrasensitive Detection of an Anthrax Biomarker. Angewandte Chemie-International Edition. 2009; 48(2): 304-308. IF=16.823

1. Ai Kelong, Liu Yanlan, Lu Lehui*. Hydrogen-Bonding Recognition-Induced Color Change of Gold Nanoparticles for Visual Detection of Melamine in Raw Milk and Infant Formula. Journal of the American Chemical Society. 2009; 131(27): 9496. IF=16.383